You are viewing the "Vaccine" Archives
COLUMBUS, Ohio (WOSU) — Ohio could see its first batch of coronavirus vaccines on December 15, Gov. Mike DeWine announced, bringing some welcome news as COVID-19 cases and hospitalizations show no indications of slowing. So far, three companies – Pfizer, AstraZeneca and Moderna – report promising results from vaccine trials, some of which have included Ohio patients…. Read More
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
Pent-up demand from households that have been cooped up over the last eight months could drive a spending boom in the spring, providing a big boost to the economy.
Pfizer’s COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.
A Senate hearing on the coronavirus pandemic follows the day after the U.S. death toll from the coronavirus pandemic topped 200,000 people. The session is underway now.
WASHINGTON, D.C. (NewsHour) — COVID-19 vaccine development continues to be the subject of political jostling, with President Trump contradicting top U.S. health officials regarding timeline and efficacy. The Centers for Disease Control and Prevention say they expect to distribute vaccines publicly at no cost to the patient. But what will the government pay, and how much… Read More
Emphasizing the continued importance of masks, Robert Redfield said that while first responders may have early access to a vaccine, broader access is not likely for six to nine months after approval.
The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.
AstraZeneca, which is working with the University of Oxford, hasn’t said what the illness is. It will try to determine whether the illness is related to the vaccine, or just a chance event.
The pledge comes one month after a survey found that only 2 in 5 Americans said they planned to get vaccinated against COVID-19.
Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?
“We’ve got to take a deep breath,” says one health official about the rapid timeline pushed for by the CDC. “It is very clear that we need to lean forward to prepare to deliver the vaccine.”
Animal and human trials are promising, Dr. Anthony Fauci told lawmakers Friday, and the government is preparing for widespread distribution once a vaccine is shown to be safe and effective.
If the company’s vaccine candidate pans out, Americans can receive it for free, under the deal. The arrangement is part of the U.S. government’s push to have a vaccine widely available by January.
The race to defeat the coronavirus is generating competition among nations and multinational companies. The main competition appears to be between the United States and China.
The race is on. What will it take to develop, test and distribute a safe and effective vaccine?